118th Congress · SENATE BILLBILL

S. 5459Biosimilars Access and Affordability Act

A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Health
Introduced Dec 9, 2024
Last action Dec 9, 2024
Pipeline · Bill → Law
Step 1
Introduced
Dec 9, 2024
Step 2
Referred
Dec 9, 2024
Finance
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in Senate
Timeline · 2 actions
Dec 9, 2024
Introduced in Senate
Dec 9, 2024
Read twice and referred to the Committee on Finance.